Disinhibition of the sleep state-dependent P1 potential in Parkinson's Disease - Improvement after pallidotomy

Sleep Research Online

Volumn 1, Issue 1, 1998, Pages 62-70

  Teo, Charles ^a   Rasco, Lisa ^a   Skinner, Robert D ^a   Garcia Rill, Edgar ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ANALYSIS OF VARIANCE; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; FEMALE; GLOBUS PALLIDUS; HABITUATION; HUMAN; MALE; MIDDLE AGED; NEUROSURGERY; PARKINSON DISEASE; PATHOPHYSIOLOGY; SLEEP;

ANALYSIS OF VARIANCE; EVOKED POTENTIALS, AUDITORY; FEMALE; GLOBUS PALLIDUS; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; LEVODOPA; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; SLEEP;

EID: 0032229148     PISSN: 1096214X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Askenasy J, Yahr M. Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy. Neurol 1985; 35: 527-32.
2. Baron MS, Vitek JL, Bakay RAE, Green J, Kaneoke Y, Hashimoto T, Turner RS, Woodard JL, Cole SA, McDonald WM, Delong MR. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1 year results of a pilot study. Ann Neurol 1996; 40: 355-66.
3. Buchwald JS, Rubinstein EH, Schwafel J, Stranburg RJ. Midlatency auditory evoked responses: Differential effects of a cholinergic agonist and antagonist. Electroenceph Clin Neurophysiol 1991; 80: 303-9.
4. Cummings JL. Depression and Parkinson's disease; a review. Amer J Psychiat 1992; 149: 443-54.
5. Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S, Fahn S. The metabolic topography of Parkinsonism. J Cereb Blood Flow Metab 1994; 14: 783-801.
6. Erwin RJ, Buchwald JS. Midlatency auditory evoked responses: Differential recovery cycle characteristics. Electroenceph Clin Neurophysiol 1986a; 64: 417-23.
7. Erwin RJ, Buchwald JS. Midlatency auditory evoked responses: Differential effects of sleep in the human. Electroenceph Clin Neurophysiol 1986b; 65: 383-92.
8. Erwin RJ, Buchwald JS. Midlatency auditory evoked responses in the human and in the cat model. In: Johnson, R, Rohrbaugh, JW, Parasweraman, R, eds. Current Trends in Event-Related Potential Research, Amsterdam: Elsevier, 1987, pp. 461-7.
9. Gillette G, Skinner RD, Rasco L, Boop FA, Garcia-Rill E. Disinhibition of the P1 midlatency auditory evoked potential in PTSD: Comparison with normal, alcoholic, and combat controls. Biol Psychiat Abst 1995; 37: 617.
10. Gillin JC, Post RM, Wyatt RJ, Goodwin FK, Synder F, Bunney WE. REM inhibitory effect of L-DOPA infusion during human sleep. Electroenceph Clin Neurophysiol 1973; 35: 181-6.
11. Granata AR, Kitai ST. Inhibitory substantia nigra inputs to the pedunculopontine neurons. Exp Brain Res 1991; 86: 459-66.
12. Green JB, Elder WW, Freed DM. The P1 component of the middle latency auditory evoked potential predicts a practice effect during clinical trials in Alzheimer's disease. Neurol 1995; 45: 962-6.
13. Harrison JB, Woolf NJ, Buchwald JS. Cholinergic neurons of the feline pontomesencephalon. II. Essential role in "Wave A" generation. Brain Res 1990; 520: 43-54.
14. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurol 1967; 17: 427-42.
15. Iacono RP, Lonser RR, Mandybur G, Morenski JD, Yamada S, Shima F. Stereotactic pallidotomy results for Parkinson's exceed those of fetal graft. Amer Surg 1994; 60: 777-82.
16. Jagust WJ, Reed BR, Martin EM, Eberling JL, Nelson-Abbott RA. Cognitive function and regional blood flow in Parkinson's disease. Brain 1992; 115: 521-37.
17. Jellinger KA. Pathology of Parkinson's disease; Changes other than the nigrostriatal pathway. Molec Med Neuropathol 1991; 14: 153-97.
18. Kales A, Ansel RD, Markham CH, Scharf MD, Tan TL. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 1971; 12: 397.
19. Kelland MD, Freeman AS, Rubin J, Chiodo LA. Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res Bull 1993; 31: 539-46.
20. Kimura J. Disorder of interneurons in Parkinsonism; the orbicularis oculi reflex to paired stimuli. Brain 1973; 96: 87-96.
21. Koch M, Kungel M, Herbert H. Cholinergic neurons in the pedunculopontine tegmental nucleus are involved in the mediation of prepulse inhibition of the acoustic startle response in the rat. Exp Brain Res 1993; 97: 71-82.
22. Lees A, Blackburn N, Campbell V. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988; 11: 512-9.
23. Maquet P, Peters J-M, Aerts J, Delfiore G, Degueldre C, Luxen A, Franck G. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature 1996; 383: 163-6.
24. Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinson's disease and anxiety; comorbidity with depression. Biol Psychiat 1993; 34: 465-70.
25. Miyazato H, Skinner RD, Garcia-Rill E. Effects of injections of GABA agonists into the pedunculopontine nucleus (PPN) on the P13 middle latency auditory evoked potential in the rat. Neurosci Abst 1996; 22: 649.
26. Miyazato H, Skinner RD, Reese NB, Garcia-Rill E. Midlatency auditory evoked potentials and the startle response in the rat. Neurosci 1997; 25: 289-300.
27. Mouret J. Differences in sleep in patients with Parkinson's disease. Electroenceph Clin Neurophysiol 1975; 38: 653-7.
28. Myslobodsky M, Mintz M, Ben-Mayor V, Radwan H. Unilateral dopamine deficit and lateral EEG asymmetry: sleep abnormalities in semi-Parkinson's patients. Electroenceph Clin Neurophysiol 1982; 54: 227-31.
29. Nausieda P, Glantz R, Weber S, Baum R, Klawans H. Psychiatric complications of levodopa therapy of Parkinson's disease. Adv Neurol 1984; 40: 271-7.
30. Noda T, Oka H. Nigral inputs to the pedunculopontine region: Intracellular analysis. Brain Res 1984; 322: 332-6.
31. Penders CA, Delwaide PJ. Blink reflex studies in patients with Parkinsonism before and during surgery. J Neurol Neurosurg Psychiat 1971; 34: 674-8.
32. Peppard RF, Martin WRW, Carr GD, Grochowski E, Schulzer M, Guttman M, McGeer PL, Phillips AG, Tsui JK, Caine DB. Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch Neurol 1992; 49: 1262-8.
33. Picton TW, Hillyard SA. Human auditory evoked potentials. II. Effects of attention. Electroenceph Clin Neurophysiol 1974; 36: 191-9.
34. Reese NB, Garcia-Rill E, Skinner RD. The pedunculopontine nucleus-auditory input, arousal and pathophysiology. Prog Neurobiol 1995; 47: 102-33.
35. Robbins TW, James M, Owen AM, Lange KW, Lees AJ, Leigh PN, Marsden CD, Quinn NP, Summers BA. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiat 1994; 57: 79-88.
36. Rothwell JC, Obeso JA, Traub MM, Marsden CD. The behavior of the long-latency stretch reflex in patients with Parkinson's disease. J Neurol Neurosurg Psychiat 1983; 46: 35-44.
37. Scarnati E, Campana E, Pacitti C. Pedunculopontine-evoked excitation of substantia nigra neurons in the rat. Brain Res 1984; 304: 351-61.
38. Stein MB, Heuser IJ. Juncos JL, Uhde TW Anxiety disorders in patients with Parkinson's disease. Amer J Psychiat 1990; 147: 217-20.
39. Steriade M, McCarley RW. Brainstem Control of Wakefulness and Sleep. New York: Plenum Press, 1990.
40. Teo C, Rasco L, Al-Mefty K, Skinner RD, Garcia-Rill E. Decreased habituation of midlatency auditory evoked responses in Parkinson's disease. Movement Dis 1997a; 12: 655-64.
41. Teo C, Rasco L, Al-Mefty K, Skinner RD, Rhodes R, Garcia-Rill E. Effect of pallidotomy on the disinhibition of the P1 midlatency auditory evoked potential in parkinsonism. Sleep Res 1997b; 26A: 49.
42. Teo C, Rasco L, Skinner RD, Harik S, Boop FA, Garcia-Rill E. Disinhibition of the P1 midlatency auditory evoked potential in Parkinson's disease. Sleep Res 1996; 25A: 34.